MBNL1 and non-small cell lung carcinoma: This study aimed to elucidate the mechanism of MBNL1-AS1 on CSCs with a view to inhibit PC malignant progression; mRNAsi has previously been used to identify stem cell-associated tumor markers in non-small cell lung cancer (NSCLC) and validate its effects [25].